The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs.EBI
Imperial College London
Oxetanes in Drug Discovery Campaigns.EBI
Imperial College London
Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase.EBI
Imperial College London
Identification of Inhibitors of the EBI
Imperial College London
Activity-based protein profiling reveals deubiquitinase and aldehyde dehydrogenase targets of a cyanopyrrolidine probe.EBI
Imperial College London
The transcriptional repressor REV-ERB as a novel target for disease.EBI
Imperial College London
On the Promise of Photopharmacology Using Photoswitches: A Medicinal Chemist's Perspective.EBI
Imperial College London
Novel Thienopyrimidine Inhibitors of EBI
Imperial College London
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus.EBI
Imperial College London
Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a.EBI
Imperial College London
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.EBI
Imperial College London